Results 211 to 220 of about 53,966 (229)

Sorafenib

Reactions Weekly, 2015
  +4 more sources

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

Lancet, The, 2014
Marcia S Brose, Rossella Elisei, Salvatore Siena   +2 more
exaly  

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

Lancet, The, 2018
Matsatoshi Kudo, Kwang-Hyub Han, Fabio Piscaglia   +2 more
exaly  

Sorafenib in Advanced Hepatocellular Carcinoma

New England Journal of Medicine, 2008
Josep M Llovet, Vincenzo Mazzaferro, Jean-Frédéric Blanc   +2 more
exaly  

Discovery and development of sorafenib: a multikinase inhibitor for treating cancer

Nature Reviews Drug Discovery, 2006
Brian Schwartz
exaly  

Sorafenib

Reactions Weekly, 2014
openaire   +2 more sources

Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma

New England Journal of Medicine, 2007
Walter M Stadler, C?zary A Szczylik, Stephane Oudard   +2 more
exaly  

N6-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating β-catenin signaling

Molecular Cancer, 2020
Kirill Gorshkov, Junhao Zheng, Xiao Liang   +2 more
exaly  

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial

Lancet, The, 2011
Brian I Rini, Andrey Kaprin, C?zary A Szczylik   +2 more
exaly  

Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models

Journal of Hematology and Oncology, 2016
Huikai Li, Tianqiang Song, HaiFang Yin
exaly